Also, the tear expression of miR-15b-5p was noticeably upregulated in the T2DM+DR patients, inhibiting the expression of their target genes, such as the TP53 gene, thus blocking the AP process in diabetics. This evidence concerns the gene TP53 and type 2 diabetes mellitus.